Reconnect

Reconnect LABS

Reconnect Labs AG is a Spin-off of the University of Zürich, with the mission to develop innovative, rapid-acting and sustainable therapies for affective disorders (anxiety, depression, trauma, addiction).

Impact-driven, patient-centered, and rooted in evidence-based research, Reconnect Labs is setting standards for a novel kind of ethical drug development company.

SUPPORT ORGANISATIONS

CORE FOUNDERS TEAM

We are a team of dedicated professionals from psychiatry,
psychology, neuroscience, pharmacology and sustainability,
working towards innovative and evidence-based
treatments
with psychedelics.

reconnect Core Founders team october 2020

Milan Scheidegger, MD, PhD, MA HPK

Founder

Fields of expertise

Psychiatry

Psychotherapy

Neuroscience

Philosophy

Milan has a multidisciplinary background in medicine (MD), neuroscience (PhD), philosophy (MA), psychiatry and psychotherapy (FMH). As a senior physician he is currently leading the Psychedelic Research & Therapy Development group at the Department of Psychiatry, Psychotherapy, and Psychosomatics (University of Zurich). Besides IP-protected innovations in the field of psychedelic drug development, he raised over 1M CHF in private and public research funds and co-founded Reconnect Labs AG as Chief Medical Officer (CMO). His contributions to the field of psychedelic therapy were acknowledged by the Young Investigators Award from the Swiss Society of Biological Psychiatry (2013) and the Inger-Salling Price for Psychiatry (2019). He is engaged in the public discourse and education around psychedelic therapy and has given talks to both academic and non-academic audiences.

Read more about Milan:

Davor Kosanic, PhD

Founder

Fields of expertise

Sustainable Entrepreneurship

INNOVATION

BUSINESS

Scientist, innovator and impact entrepreneur. Co-founder of the Reconnect Foundation. Catalyzer of sustainable innovation and regenerative entrepreneurship ecosystems at EPFL – a leading Swiss technology institute. Previously, Davor has acquired his entrepreneurial expertise as founder and CEO of SamanTree Medical, which has developed and commercialized an award-winning imaging device for cancer surgery.

Read more about Davor:

Michael Kometer, PhD

Founder

Fields of expertise

NEUROPSYCHOLOGY

Finance

BUSINESS

Dr. Michael Kometer has conducted numerous scientific studies on the effects of psychedelics in humans, leading to more than 20 highly-cited publications on the topic. In particular, he has been at the forefront of investigating the therapeutic potential of serotonergic psychedelics and conducted the first human study on the effects of psilocybin on emotional processing. Furthermore, he worked as a senior researcher in the financial industry and at the Geneva Finance Research institute. He is co-founder and chairman of Neuronomics, a Startup into neuroscientific-based algorithmic trading.

Read more about Michael:

LinkedIn

Dario DORNBIERER, PhD

Founder

Fields of expertise

Psychopharmacology

Drug Development

Neuroscience

Dario Dornbierer is a pharmaceutical scientist (ETH Zurich). In his previous work, Dario investigated the pharmacological effects of GHB on sleep neurophysiology, neuroimmune interactions and brain metabolism in humans. Furthermore, he developed and tested an innovative nutraceutical product for the treatment of wake-up difficulties. During an UZH Entrepreneur and a Bridge PoC Fellowship he invented and tested an innovative “ayahuasca” formulation, designed to treat affective disorders in a safe, efficacious and patient-oriented manner. His main interest comprises applying pharmaceutical technologies to advance psychiatric drug development.
 

Read more about Dario:

mr unknown

Co-Founder

Fields of expertise

NEUROPSYCHOLOGY

Finance

BUSINESS

Red flag new economy this medium needs to be more dynamic or target rich environment, so Bob called an all-hands this afternoon, nor optimize the fireball yet you gotta smoke test your hypothesis. Run it up the flagpole, ping the boss and circle back upstream selling, or meeting assassin knowledge process outsourcing yet we’re all in this together, even if our businesses function differently. Closer to the metal. Get all your ducks in a row. Root-and-branch review hard stop. Five-year strategic plan optimize for search minimize backwards overflow single wringable neck nor can you ballpark the cost per unit.

Read more about Milan:

Linkedln

Research gate